New treatment tested for rare stomach condition
NCT ID NCT06317220
Summary
This study is testing whether vedolizumab, a medication given through an IV, can help control symptoms of collagenous gastritis—a rare stomach condition. Eleven participants aged 14+ with confirmed diagnosis and symptoms will receive infusions and be monitored for symptom changes and safety over about a year. Researchers will check if the treatment reduces stomach symptoms and is safe for people with this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLLAGENOUS GASTRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.